Health Catalyst, Inc. (NASDAQ:HCAT) Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC raised its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 0.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,446,600 shares of the company’s stock after purchasing an additional 3,564 shares during the period. Geode Capital Management LLC owned 2.38% of Health Catalyst worth $10,230,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quantbot Technologies LP acquired a new position in shares of Health Catalyst during the fourth quarter worth approximately $29,000. Stoneridge Investment Partners LLC bought a new stake in Health Catalyst during the 4th quarter valued at $77,000. Virtu Financial LLC bought a new stake in Health Catalyst during the 4th quarter valued at $110,000. Dynamic Advisor Solutions LLC acquired a new position in Health Catalyst during the 4th quarter worth $180,000. Finally, Avanza Fonder AB bought a new position in shares of Health Catalyst in the fourth quarter worth $184,000. Institutional investors own 85.00% of the company’s stock.

Insider Transactions at Health Catalyst

In related news, COO Daniel Lesueur sold 5,209 shares of Health Catalyst stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $5.76, for a total value of $30,003.84. Following the transaction, the chief operating officer now owns 86,044 shares of the company’s stock, valued at approximately $495,613.44. This trade represents a 5.71 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Linda Llewelyn sold 6,441 shares of the company’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $5.43, for a total transaction of $34,974.63. Following the sale, the insider now directly owns 85,819 shares of the company’s stock, valued at $465,997.17. This represents a 6.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 47,588 shares of company stock valued at $225,906 over the last three months. Company insiders own 2.50% of the company’s stock.

Health Catalyst Price Performance

Shares of NASDAQ:HCAT opened at $3.66 on Wednesday. The company has a market capitalization of $256.97 million, a PE ratio of -2.71 and a beta of 1.43. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41. The stock has a fifty day moving average of $4.39 and a 200-day moving average of $6.30. Health Catalyst, Inc. has a one year low of $3.56 and a one year high of $9.24.

Analysts Set New Price Targets

Several research firms recently weighed in on HCAT. Canaccord Genuity Group reduced their price objective on shares of Health Catalyst from $11.00 to $10.00 and set a “buy” rating for the company in a report on Tuesday, January 21st. Citigroup reduced their price target on shares of Health Catalyst from $10.50 to $10.00 and set a “buy” rating for the company in a research note on Friday, January 10th. Stifel Nicolaus lowered their price objective on shares of Health Catalyst from $10.00 to $5.00 and set a “hold” rating on the stock in a research note on Thursday, February 27th. Wells Fargo & Company cut their target price on Health Catalyst from $13.00 to $10.00 and set an “overweight” rating for the company in a research report on Tuesday, January 21st. Finally, Evercore ISI lowered Health Catalyst from an “outperform” rating to an “inline” rating in a research note on Wednesday, April 9th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Health Catalyst presently has an average rating of “Moderate Buy” and an average target price of $8.36.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.